LogicBio Therapeutics, Inc. Quarterly Return On Equity in % from Q4 2018 to Q3 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
LogicBio Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2018 to Q3 2022.
  • LogicBio Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2022 was -115 %, a 51.7% decline year-over-year.
  • LogicBio Therapeutics, Inc. annual Return On Equity for 2021 was -95 %, a 5.99% decline from 2020.
  • LogicBio Therapeutics, Inc. annual Return On Equity for 2020 was -89.6 %, a 29.4% decline from 2019.
  • LogicBio Therapeutics, Inc. annual Return On Equity for 2019 was -69.3 %, a 64.1% increase from 2018.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2022 -115 -39.3 -51.7% Jul 1, 2022 Sep 30, 2022
Q2 2022 -108 -29.4 -37.6% Apr 1, 2022 Jun 30, 2022
Q1 2022 -105 -24.1 -29.9% Jan 1, 2022 Mar 31, 2022
Q4 2021 -95 -5.37 -5.99% Oct 1, 2021 Dec 31, 2021
Q3 2021 -76 +41.6 +35.4% Jul 1, 2021 Sep 30, 2021
Q2 2021 -78.2 +23.7 +23.2% Apr 1, 2021 Jun 30, 2021
Q1 2021 -80.6 +6.44 +7.4% Jan 1, 2021 Mar 31, 2021
Q4 2020 -89.6 -20.4 -29.4% Oct 1, 2020 Dec 31, 2020
Q3 2020 -118 -64.7 -122% Jul 1, 2020 Sep 30, 2020
Q2 2020 -102 -42.3 -70.9% Apr 1, 2020 Jun 30, 2020
Q1 2020 -87 -10.4 -13.6% Jan 1, 2020 Mar 31, 2020
Q4 2019 -69.3 +124 +64.1% Oct 1, 2019 Dec 31, 2019
Q3 2019 -53 Jul 1, 2019 Sep 30, 2019
Q2 2019 -59.6 Apr 1, 2019 Jun 30, 2019
Q1 2019 -76.6 Jan 1, 2019 Mar 31, 2019
Q4 2018 -193 Oct 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.